Announcement of Performance of Domestic 136 Medical Device Enterprises in 2022

In 2022, the combined revenue of 136 listed medical device enterprises was 397.229 billion yuan, up 24% year-on-year from 319.107 billion yuan in 2021. Among them: there were 8 10 billion enterprises, of which 6 belong to the in vitro diagnostic section; 44 enterprises had negative revenue growth in 2022, accounting for nearly 1/3, mainly medical consumables and equipment enterprises; and 7 enterprises had revenue growth rates of more than 100, which were Andon Medical, EasyDiagnosis, Assuretech, Hybribio, Labway, Yhlo, Bmc-medical.;, of which 64 enterprises return home net profit was negative, accounting for nearly half.

Overall, the development of the medical device industry maintained a stable growth in 2022. Affected by the epidemic, some in vitro diagnosis enterprises had achieved a leap forward development, while the revenue of high-value consumables enterprises had declined to a certain extent due to the decline in the amount of diagnosis and treatment in terminal medical institutions and the continuous “acceleration and expansion” of centralized procurement with volume.

Source：Medical Device Supply Chain Association of CFLP

Translated & edited ： Bradyknows